Joel S. Schuman, MD

How will ophthalmologists watch the eclipse?
How will ophthalmologists watch the eclipse?Ophthalmologists all know how to safely watch an eclipse, but how will ophthalmologists around the country be participating in and observing the event?
What you missed at Glaucoma 360 this year
What you missed at Glaucoma 360 this yearSee the highlights and program overview from the Glaucoma Research Foundation's 2017 Glaucoma 360!
How OCT innovations are changing glaucoma careOptical coherence tomography (OCT) is swiftly improving the diagnosis of glaucoma, according to Joel S. Schuman, MD, who helped invent the technology.
Improvements in detecting and measuring glaucoma round out 2015As 2015 progressed, researchers reported better ways to detect glaucoma, measure the damage it is causing, and understand how that damage is affecting their patients’ lives. No single innovation revolutionized the profession, but a wide range of technologies became more available to clinicians.
App coined ‘Instagram for doctors’ makes waves
App coined ‘Instagram for doctors’ makes wavesA novel photo-sharing app will most definitely not be named ‘the new Instagram’ for those who enjoy posting selfies or photos of their cats.
Joel Schuman, MD, discusses Glaucoma 360 and the Catalyst for a CureJoel Schuman, MD, FACS, director of the UPMC Eye Center at the University of Pittsburgh, discusses the upcoming Glaucoma 360 meeting and the Catalyst for a Cure. The meeting is planned for Feb. 5-7 in San Francisco. Both programs are part of Glaucoma Research Foundation's mission to prevent vision loss from glaucoma by investing in innovative research.
Glaucoma specialists focus attention on forthcoming advances, therapiesSpecialists in glaucoma anticipate the future availability of a novel triple-action agent, as well as other medical and surgical management developments.
Market adoption of MIGS growingExperts discuss the growing market of MIGS, as well as their benefits and possible concerns, while examining alternative non-invasive intervention methods.
Glaucoma diagnostics research focuses on novel, existing toolsGlaucoma experts analyze the hardware and software developments that came out of 2013, while noting several changes that still need to be addressed for the best utilization of the technology.
Glaucoma medical therapy sees new approvalsNew products and medications for surgery became available in 2013, while a heavy eye remained concentrated on the cost of generics.